S&P 500 Futures
(0.12%) 5 137.75 points
Dow Jones Futures
(0.08%) 38 472 points
Nasdaq Futures
(0.18%) 17 877 points
Oil
(-0.31%) $83.59
Gas
(1.56%) $1.953
Gold
(0.29%) $2 354.10
Silver
(0.56%) $27.69
Platinum
(1.45%) $935.50
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.34%) $10.99
USD/GBP
(-0.28%) $0.798
USD/RUB
(1.24%) $93.01

リアルタイムの更新: UDG Healthcare plc [UDG.L]

取引所: LSE 産業: Health Care Equipment & Services
最終更新日時1 1月 1970 @ 09:00

0.09% £ 1 079.00

Live Chart Being Loaded With Signals

Commentary (1 1月 1970 @ 09:00):

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally...

Stats
本日の出来高 3.14M
平均出来高 2.82M
時価総額 0.00
EPS £0.0573 ( 2019-06-29 )
Last Dividend £0.125 ( 2021-01-07 )
Next Dividend £0 ( N/A )
P/E 0.420
ATR14 £0 (0.00%)

UDG Healthcare plc 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

UDG Healthcare plc 財務諸表

Annual 2020
収益: £1.28B
総利益: £394.83M (30.87 %)
EPS: £0.373
FY 2020
収益: £1.28B
総利益: £394.83M (30.87 %)
EPS: £0.373
FY 2019
収益: £1.30B
総利益: £371.14M (28.58 %)
EPS: £0.231
FY 2018
収益: £1.32B
総利益: £381.60M (29.02 %)
EPS: £0.0153

Financial Reports:

No articles found.

UDG Healthcare plc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

UDG Healthcare plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.26 - Potential for dividend initiation, but uncertain (5.20%)
Information
First Dividend £0.00468 1990-01-29
Last Dividend £0.125 2021-01-07
Next Dividend £0 N/A
Payout Date 2021-02-05
Next Payout Date N/A
# dividends 63 --
Total Paid Out £1.931 --
Avg. Dividend % Per Year 0.00% --
Score 4.03 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.26
Div. Directional Score 8.01 --
Next Divdend (Est)
(2024-06-21)
£0 Estimate 0.00 %
Dividend Stability
0.09 Very Bad
Dividend Score
4.03
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
1990 £0 0.00%
1991 £0 0.00%
1992 £0 0.00%
1993 £0 0.00%
1994 £0 0.00%
1995 £0 0.00%
1996 £0 0.00%
1997 £0 0.00%
1998 £0 0.00%
1999 £0 0.00%
2000 £0 0.00%
2001 £0 0.00%
2002 £0 0.00%
2003 £0 0.00%
2004 £0 0.00%
2005 £0 0.00%
2006 £0 0.00%
2007 £0 0.00%
2008 £0 0.00%
2009 £0 0.00%
2010 £0 0.00%
2011 £0 0.00%
2012 £0 0.00%
2013 £0 0.00%
2014 £0 0.00%
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0.168 0.02%
2021 £0.125 0.02%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SHG.L Dividend Knight 2023-11-02 Semi-Annually 4 0.91%
IHP.L Dividend Knight 2023-06-08 Semi-Annually 7 1.08%
BOCH.L Dividend Junior 2023-05-04 Insufficient data to determine frequency 2 1.10%
OCN.L Dividend Knight 2023-05-18 Annually 19 3.96%
ESNT.L Dividend King 2023-09-21 Semi-Annually 20 4.44%
STAN.L Dividend Junior 2023-08-10 Annually 32 1.92%
JMAT.L Dividend Knight 2023-06-08 Semi-Annually 33 1.93%
CAPD.L Dividend King 2023-08-31 Semi-Annually 10 2.58%
PSHD.L No Dividend Player 2023-08-17 Annually 6 0.41%
GCP.L Dividend King 2023-08-10 Quarterly 15 3.86%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07261.5008.5510.00[0 - 0.5]
returnOnAssetsTTM0.05261.2008.259.90[0 - 0.3]
returnOnEquityTTM0.09861.500-0.0160-0.0240[0.1 - 1]
payoutRatioTTM0.453-1.0005.47-5.47[0 - 1]
currentRatioTTM1.9190.8005.414.32[1 - 3]
quickRatioTTM0.7910.800-0.0553-0.0442[0.8 - 2.5]
cashRatioTTM0.7911.5006.7210.00[0.2 - 2]
debtRatioTTM0.167-1.5007.22-10.00[0 - 0.6]
interestCoverageTTM8.871.0007.837.83[3 - 30]
operatingCashFlowPerShareTTM0.9262.009.6910.00[0 - 30]
freeCashFlowPerShareTTM0.7742.009.6110.00[0 - 20]
debtEquityRatioTTM0.299-1.5008.81-10.00[0 - 2.5]
grossProfitMarginTTM0.3091.0008.198.19[0.2 - 0.8]
operatingProfitMarginTTM0.09951.000-0.0102-0.0102[0.1 - 0.6]
cashFlowToDebtRatioTTM0.7851.0006.756.75[0.2 - 2]
assetTurnoverTTM0.7250.8008.506.80[0.5 - 2]
Total Score10.75

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM36.301.0006.430[1 - 100]
returnOnEquityTTM0.09862.50-0.0103-0.0240[0.1 - 1.5]
freeCashFlowPerShareTTM0.7742.009.7410.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.9262.009.6910.00[0 - 30]
payoutRatioTTM0.4531.5005.47-5.47[0 - 1]
pegRatioTTM47.571.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1801.0007.990[0.1 - 0.5]
Total Score5.26

UDG Healthcare plc

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。